Detalhe da pesquisa
1.
Tyrosine Kinase Inhibitor Activity in Patients with NSCLC Harboring Uncommon EGFR Mutations: A Retrospective International Cohort Study (UpSwinG).
Oncologist
; 27(4): 255-265, 2022 04 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35274704
2.
Lazertinib in patients with EGFR mutation-positive advanced non-small-cell lung cancer: results from the dose escalation and dose expansion parts of a first-in-human, open-label, multicentre, phase 1-2 study.
Lancet Oncol
; 20(12): 1681-1690, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31587882
3.
Improving trends in survival of patients who receive chemotherapy for metastatic or recurrent gastric cancer: 12 years of experience at a single institution.
Gastric Cancer
; 18(2): 346-53, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24832201
4.
Genomic predictors for recurrence patterns of hepatocellular carcinoma: model derivation and validation.
PLoS Med
; 11(12): e1001770, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25536056
5.
Real-world treatment patterns and clinical outcomes in patients with stage III NSCLC in Korea: The KINDLE study.
Cancer Med
; 13(7): e7174, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38622869
6.
Lazertinib versus Gefitinib as First-Line Treatment for EGFR-mutated Locally Advanced or Metastatic NSCLC: LASER301 Korean Subset.
Cancer Res Treat
; 56(1): 48-60, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37402411
7.
A Phase 3 Randomized Clinical Trial to Compare Efficacy and Safety between Combination Therapy and Monotherapy in Elderly Patients with Advanced Gastric Cancer (KCSG ST13-10).
Cancer Res Treat
; 55(4): 1250-1260, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37232070
8.
Lazertinib Versus Gefitinib Tyrosine Kinase Inhibitors in Treatment-Naíve Patients With EGFR-Mutated Advanced NSCLC: Analysis of the Asian Subpopulation in LASER301.
J Thorac Oncol
; 18(10): 1351-1361, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37702629
9.
Central Nervous System Outcomes of Lazertinib Versus Gefitinib in EGFR-Mutated Advanced NSCLC: A LASER301 Subset Analysis.
J Thorac Oncol
; 18(12): 1756-1766, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37865896
10.
A pilot study of S-1 plus cisplatin versus 5-fluorouracil plus cisplatin for postoperative chemotherapy in histological stage IIIB-IV (M0) gastric cancer.
Invest New Drugs
; 30(1): 357-63, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-20734110
11.
A Phase II study of clinical outcomes of 3-week cycles of irinotecan and S-1 in patients with previously untreated metastatic colorectal cancer: influence of the UGT1A1 and CYP2A6 polymorphisms on clinical activity.
Oncology
; 82(5): 290-7, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22555197
12.
Randomized phase II trial of S-1 and cisplatin versus gemcitabine and cisplatin in patients with advanced biliary tract adenocarcinoma.
Acta Oncol
; 51(7): 860-6, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22559158
13.
Three-week combination chemotherapy with S-1 and cisplatin as first-line treatment in patients with advanced gastric cancer: a retrospective study with 159 patients.
Gastric Cancer
; 15(3): 305-12, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22160244
14.
A Multicenter Two-arm, Phase II Trial Assessing the Safety and Efficacy of First-line Lazertinib and Locally Ablative Radiotherapy in Patients With Synchronous Oligo-metastatic EGFR-mutant Non-small Cell Lung Cancer (ABLATE, KCSG-LU21-11).
Clin Lung Cancer
; 23(8): e536-e539, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36002368
15.
A Phase 1/2 Study of Lazertinib 240 mg in Patients With Advanced EGFR T790M-Positive NSCLC After Previous EGFR Tyrosine Kinase Inhibitors.
J Thorac Oncol
; 17(4): 558-567, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34958928
16.
YH29407 with anti-PD-1 ameliorates anti-tumor effects via increased T cell functionality and antigen presenting machinery in the tumor microenvironment.
Front Chem
; 10: 998013, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36545214
17.
SKI-G-801, an AXL kinase inhibitor, blocks metastasis through inducing anti-tumor immune responses and potentiates anti-PD-1 therapy in mouse cancer models.
Clin Transl Immunology
; 11(1): e1364, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35003748
18.
Biochemical characterization of metnase's endonuclease activity and its role in NHEJ repair.
Biochemistry
; 50(20): 4360-70, 2011 May 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-21491884
19.
Clinical features and course of brain metastases in triple-negative breast cancer: comparison with human epidermal growth factor receptor 2-positive and other type at single institution in Korea.
Breast Cancer Res Treat
; 128(1): 171-7, 2011 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-21519835
20.
Initial cytoreductive treatment with thalidomide plus bolus vincristine/doxorubicin and reduced dexamethasone followed by autologous stem cell transplantation for multiple myeloma.
Invest New Drugs
; 29(1): 175-81, 2011 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-19823768